Critical role of Bcl11b in suppressor function of T regulatory cells and prevention of inflammatory bowel disease

Jeffrey VanValkenburgh, Diana I. Albu, Chandra Bapanpally, Sarah Casanova, Danielle Califano, David M. Jones, Leszek Ignatowicz, Shimpei Kawamoto, Sidonia Fagarasan, Nancy A. Jenkins, Neal G. Copeland, Pentao Liu, Dorina Avram

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Dysregulated CD4+ T cell responses and alterations in T regulatory cells (Treg cells) play a critical role in autoimmune diseases, including inflammatory bowel disease (IBD). The current study demonstrates that removal of Bcl11b at the double-positive stage of T cell development or only in Treg cells causes IBD because of proinflammatory cytokine-producing CD4+ T cells infiltrating the colon. Provision of WT Treg cells prevented IBD, demonstrating that alterations in Treg cells are responsible for the disease. Furthermore, Bcl11b-deficient Treg cells had reduced suppressor activity with altered gene expression profiles, including reduced expression of the genes encoding Foxp3 and IL-10, and up-regulation of genes encoding proinflammatory cytokines. Additionally, the absence of Bcl11b altered the induction of Foxp3 expression and reduced the generation of induced Treg cells (iTreg cells) after Tgf-β treatment of conventional CD4+ T cells. Bcl11b bound to Foxp3 and IL-10 promoters, as well as to critical conserved noncoding sequences within the Foxp3 and IL-10 loci, and mutating the Bcl11b binding site in the Foxp3 promoter reduced expression of a luciferase reporter gene. These experiments demonstrate that Bcl11b is indispensable for Treg suppressor function and for maintenance of optimal Foxp3 and IL-10 gene expression, as well as for the induction of Foxp3 expression in conventional CD4+ T cells in response to Tgf-β and generation of iTreg cells.

Original languageEnglish (US)
Pages (from-to)2069-2081
Number of pages13
JournalJournal of Experimental Medicine
Volume208
Issue number10
DOIs
StatePublished - Sep 26 2011

Fingerprint

Regulatory T-Lymphocytes
Inflammatory Bowel Diseases
Interleukin-10
T-Lymphocytes
Cytokines
Gene Expression
Conserved Sequence
Luciferases
Reporter Genes
Transcriptome
Autoimmune Diseases
Colon
Up-Regulation
Binding Sites
Maintenance
Genes

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

VanValkenburgh, J., Albu, D. I., Bapanpally, C., Casanova, S., Califano, D., Jones, D. M., ... Avram, D. (2011). Critical role of Bcl11b in suppressor function of T regulatory cells and prevention of inflammatory bowel disease. Journal of Experimental Medicine, 208(10), 2069-2081. https://doi.org/10.1084/jem.20102683

Critical role of Bcl11b in suppressor function of T regulatory cells and prevention of inflammatory bowel disease. / VanValkenburgh, Jeffrey; Albu, Diana I.; Bapanpally, Chandra; Casanova, Sarah; Califano, Danielle; Jones, David M.; Ignatowicz, Leszek; Kawamoto, Shimpei; Fagarasan, Sidonia; Jenkins, Nancy A.; Copeland, Neal G.; Liu, Pentao; Avram, Dorina.

In: Journal of Experimental Medicine, Vol. 208, No. 10, 26.09.2011, p. 2069-2081.

Research output: Contribution to journalArticle

VanValkenburgh, J, Albu, DI, Bapanpally, C, Casanova, S, Califano, D, Jones, DM, Ignatowicz, L, Kawamoto, S, Fagarasan, S, Jenkins, NA, Copeland, NG, Liu, P & Avram, D 2011, 'Critical role of Bcl11b in suppressor function of T regulatory cells and prevention of inflammatory bowel disease', Journal of Experimental Medicine, vol. 208, no. 10, pp. 2069-2081. https://doi.org/10.1084/jem.20102683
VanValkenburgh, Jeffrey ; Albu, Diana I. ; Bapanpally, Chandra ; Casanova, Sarah ; Califano, Danielle ; Jones, David M. ; Ignatowicz, Leszek ; Kawamoto, Shimpei ; Fagarasan, Sidonia ; Jenkins, Nancy A. ; Copeland, Neal G. ; Liu, Pentao ; Avram, Dorina. / Critical role of Bcl11b in suppressor function of T regulatory cells and prevention of inflammatory bowel disease. In: Journal of Experimental Medicine. 2011 ; Vol. 208, No. 10. pp. 2069-2081.
@article{fa27b3e5bef34bcab323d3040c3a1b57,
title = "Critical role of Bcl11b in suppressor function of T regulatory cells and prevention of inflammatory bowel disease",
abstract = "Dysregulated CD4+ T cell responses and alterations in T regulatory cells (Treg cells) play a critical role in autoimmune diseases, including inflammatory bowel disease (IBD). The current study demonstrates that removal of Bcl11b at the double-positive stage of T cell development or only in Treg cells causes IBD because of proinflammatory cytokine-producing CD4+ T cells infiltrating the colon. Provision of WT Treg cells prevented IBD, demonstrating that alterations in Treg cells are responsible for the disease. Furthermore, Bcl11b-deficient Treg cells had reduced suppressor activity with altered gene expression profiles, including reduced expression of the genes encoding Foxp3 and IL-10, and up-regulation of genes encoding proinflammatory cytokines. Additionally, the absence of Bcl11b altered the induction of Foxp3 expression and reduced the generation of induced Treg cells (iTreg cells) after Tgf-β treatment of conventional CD4+ T cells. Bcl11b bound to Foxp3 and IL-10 promoters, as well as to critical conserved noncoding sequences within the Foxp3 and IL-10 loci, and mutating the Bcl11b binding site in the Foxp3 promoter reduced expression of a luciferase reporter gene. These experiments demonstrate that Bcl11b is indispensable for Treg suppressor function and for maintenance of optimal Foxp3 and IL-10 gene expression, as well as for the induction of Foxp3 expression in conventional CD4+ T cells in response to Tgf-β and generation of iTreg cells.",
author = "Jeffrey VanValkenburgh and Albu, {Diana I.} and Chandra Bapanpally and Sarah Casanova and Danielle Califano and Jones, {David M.} and Leszek Ignatowicz and Shimpei Kawamoto and Sidonia Fagarasan and Jenkins, {Nancy A.} and Copeland, {Neal G.} and Pentao Liu and Dorina Avram",
year = "2011",
month = "9",
day = "26",
doi = "10.1084/jem.20102683",
language = "English (US)",
volume = "208",
pages = "2069--2081",
journal = "Journal of Experimental Medicine",
issn = "0022-1007",
publisher = "Rockefeller University Press",
number = "10",

}

TY - JOUR

T1 - Critical role of Bcl11b in suppressor function of T regulatory cells and prevention of inflammatory bowel disease

AU - VanValkenburgh, Jeffrey

AU - Albu, Diana I.

AU - Bapanpally, Chandra

AU - Casanova, Sarah

AU - Califano, Danielle

AU - Jones, David M.

AU - Ignatowicz, Leszek

AU - Kawamoto, Shimpei

AU - Fagarasan, Sidonia

AU - Jenkins, Nancy A.

AU - Copeland, Neal G.

AU - Liu, Pentao

AU - Avram, Dorina

PY - 2011/9/26

Y1 - 2011/9/26

N2 - Dysregulated CD4+ T cell responses and alterations in T regulatory cells (Treg cells) play a critical role in autoimmune diseases, including inflammatory bowel disease (IBD). The current study demonstrates that removal of Bcl11b at the double-positive stage of T cell development or only in Treg cells causes IBD because of proinflammatory cytokine-producing CD4+ T cells infiltrating the colon. Provision of WT Treg cells prevented IBD, demonstrating that alterations in Treg cells are responsible for the disease. Furthermore, Bcl11b-deficient Treg cells had reduced suppressor activity with altered gene expression profiles, including reduced expression of the genes encoding Foxp3 and IL-10, and up-regulation of genes encoding proinflammatory cytokines. Additionally, the absence of Bcl11b altered the induction of Foxp3 expression and reduced the generation of induced Treg cells (iTreg cells) after Tgf-β treatment of conventional CD4+ T cells. Bcl11b bound to Foxp3 and IL-10 promoters, as well as to critical conserved noncoding sequences within the Foxp3 and IL-10 loci, and mutating the Bcl11b binding site in the Foxp3 promoter reduced expression of a luciferase reporter gene. These experiments demonstrate that Bcl11b is indispensable for Treg suppressor function and for maintenance of optimal Foxp3 and IL-10 gene expression, as well as for the induction of Foxp3 expression in conventional CD4+ T cells in response to Tgf-β and generation of iTreg cells.

AB - Dysregulated CD4+ T cell responses and alterations in T regulatory cells (Treg cells) play a critical role in autoimmune diseases, including inflammatory bowel disease (IBD). The current study demonstrates that removal of Bcl11b at the double-positive stage of T cell development or only in Treg cells causes IBD because of proinflammatory cytokine-producing CD4+ T cells infiltrating the colon. Provision of WT Treg cells prevented IBD, demonstrating that alterations in Treg cells are responsible for the disease. Furthermore, Bcl11b-deficient Treg cells had reduced suppressor activity with altered gene expression profiles, including reduced expression of the genes encoding Foxp3 and IL-10, and up-regulation of genes encoding proinflammatory cytokines. Additionally, the absence of Bcl11b altered the induction of Foxp3 expression and reduced the generation of induced Treg cells (iTreg cells) after Tgf-β treatment of conventional CD4+ T cells. Bcl11b bound to Foxp3 and IL-10 promoters, as well as to critical conserved noncoding sequences within the Foxp3 and IL-10 loci, and mutating the Bcl11b binding site in the Foxp3 promoter reduced expression of a luciferase reporter gene. These experiments demonstrate that Bcl11b is indispensable for Treg suppressor function and for maintenance of optimal Foxp3 and IL-10 gene expression, as well as for the induction of Foxp3 expression in conventional CD4+ T cells in response to Tgf-β and generation of iTreg cells.

UR - http://www.scopus.com/inward/record.url?scp=80555139651&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80555139651&partnerID=8YFLogxK

U2 - 10.1084/jem.20102683

DO - 10.1084/jem.20102683

M3 - Article

C2 - 21875956

AN - SCOPUS:80555139651

VL - 208

SP - 2069

EP - 2081

JO - Journal of Experimental Medicine

JF - Journal of Experimental Medicine

SN - 0022-1007

IS - 10

ER -